Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_36784 | 15 | 0.30 | Mlig455_046783, Mlig455_069957 | Neo: - Age: logFC(26M/2M)=-0.515 |
Mlig455_046783 {REF} {Length: 1605} {RNA1509_14365} {RNA1310_13117.2} {RNA815_6458.1} Mlig455_069957 {REF} {Length: 1377} {RNA1509_14365} {RNA1310_13117.4} {RNA815_6458.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.462 | 0.84 | 1.00000 | 1.00000 | |
RegionR2 | 0.581 | 0.84 | 1.00000 | 1.00000 | |
RegionR3 | 1.546 | 0.84 | 0.99719 | 1.00000 | |
RegionR4 | 0.131 | 0.84 | 0.18561 | 0.45826 | |
RegionR5 | -0.266 | 0.84 | 0.97563 | 1.00000 | |
RegionR6 | -1.265 | 0.84 | 1.00000 | 1.00000 | |
RegionR7 | 0.137 | 0.84 | 1.00000 | 1.00000 | |
RegionR8 | 0.599 | 0.84 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.724 | 0.84 | 1.00000 | 1.00000 | |
RegenerationR2 | 2.262 | 0.84 | 0.20705 | 0.65434 | |
RegenerationR3 | 1.453 | 0.84 | 0.45625 | 0.83586 | |
RegenerationR4 | 1.503 | 0.84 | 0.41624 | 0.82401 | |
RegenerationR5 | 0.965 | 0.84 | 0.47884 | 0.84645 | |
RegenerationR6 | 3.172 | 0.84 | 0.64118 | 0.89389 | |
RegenerationBL | -0.353 | 0.84 | 1.00000 | 1.00000 | |
RegenerationTP | -0.315 | 0.84 | 0.99984 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_36784 | 15 | 0.3 | Mlig455_046783, Mlig455_069957 | Neo: - Age: logFC(26M/2M)=-0.515 |
2 | 1.000 | - | - | - | 1.000 | - | Mlig455_046783 {REF} {Length: 1605} {RNA1509_14365} {RNA1310_13117.2} {RNA815_6458.1} Mlig455_069957 {REF} {Length: 1377} {RNA1509_14365} {RNA1310_13117.4} {RNA815_6458.1} |
|
2. | MligTC455_36197 | 92 | 1.91 | Mlig455_053513 | Neo: - |
TNS1 | 0.993 | - | - | - | - | 0.993 | - | Mlig455_053513 {REF} {Length: 3575} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=47.7]; SH2 domain [PF00017.26, score=40.2]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=177, Expect=7e-45]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=176, Expect=8e-45]; ENSMUSG00000020422, Tns3, tensin 3, [Score=169, Expect=9e-43]} {Dmel: FBgn0000244, by, blistery, [Score=166, Expect=2e-42]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=181, Expect=5e-51]} {Smed: dd_Smed_v6_4494_0_2, dd_Smed_v6_4494_0_2, [Score=181, Expect=5e-48]} {RNA1509_28824, RNA1509_50496} {RNA1310_7318, RNA1509_28824, RNA1509_50496} {RNA1509_28824, RNA1509_50496, RNA815_6926} |
3. | MligTC455_36198 | 102 | 2.13 | Mlig455_061010 | Neo: - Age: - |
TNS1 | 0.992 | - | - | - | - | 0.992 | - | Mlig455_061010 {REF} {Length: 1601} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=49.9]; SH2 domain [PF00017.26, score=30.3]} {Human: ENSG00000079308, TNS1, tensin 1, [Score=155, Expect=5e-42]; ENSG00000136205, TNS3, tensin 3, [Score=151, Expect=2e-40]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=155, Expect=2e-42]; ENSMUSG00000020422, Tns3, tensin 3, [Score=154, Expect=1e-41]} {Dmel: FBgn0000244, by, blistery, [Score=150, Expect=8e-41]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=164, Expect=2e-48]} {Smed: dd_Smed_v6_4454_0_5, dd_Smed_v6_4454_0_5, [Score=153, Expect=5e-45]} {RNA1509_28824} {RNA1310_20281} {RNA815_21042} |
4. | MligTC455_57417 | 27 | 0.56 | Mlig455_045382 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_045382 {REF} {Length: 268} {NoTransDecoderORF} | |
5. | MligTC455_00744 | 5 | 0.11 | Mlig455_027706 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_027706 {REF} {Length: 520} {NoTransDecoderORF} {RNA1310_47876.2} {RNA815_62057} | |
6. | MligTC455_17759 | 25 | 0.53 | Mlig455_032815 | Neo: - Age: Up-Up-Down |
0.973 | - | - | - | - | 0.973 | - | Mlig455_032815 {REF} {Length: 1891} {Pfam: Protein of unknown function (DUF2673) [PF10880.10, score=53.5]} {RNA1509_57582} {RNA1310_49538.1, RNA1509_57582} | |
7. | MligTC455_36274 | 15 | 0.31 | Mlig455_008085 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_008085 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_32205} {RNA1310_64038} {RNA815_49379} | |
8. | MligTC455_50866 | 73 | 1.53 | Mlig455_052918 | Neo: Int S/G2/M Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_052918 {REF} {Length: 3299} {RNA1509_20768} {RNA1310_18267} {RNA815_37080} | |
9. | MligTC455_24612 | 12 | 0.25 | Mlig455_000425, Mlig455_000489, Mlig455_000526, Mlig455_024858 | Neo: - Age: - |
SCN1A | 0.962 | - | - | - | - | 0.962 | - | Mlig455_000425 {REF} {Length: 2186} {Pfam: Ion transport protein [PF00520.33, score=296.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.9]; Polycystin cation channel [PF08016.14, score=23.2]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=502, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=498, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=490, Expect=7e-153]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=486, Expect=2e-151]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=486, Expect=9e-152]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=481, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=481, Expect=4e-150]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=500, Expect=7e-157]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=494, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=490, Expect=4e-153]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=484, Expect=2e-151]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=484, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=483, Expect=1e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=481, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=475, Expect=6e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=538, Expect=2e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=189, Expect=6e-50]} {Smed: dd_Smed_v6_13973_0_1, dd_Smed_v6_13973_0_1, [Score=610, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000489 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=23.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=504, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=9e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=1e-151]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=483, Expect=9e-150]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=482, Expect=8e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=479, Expect=4e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=2e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=1e-150]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=483, Expect=6e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=5e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=627, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000526 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.7]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=22.9]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=503, Expect=3e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=8e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=8e-152]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=484, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=483, Expect=6e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=478, Expect=5e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=3e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=2e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=484, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=6e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=628, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_024858 {REF} {Length: 1954} {Pfam: Ion transport protein [PF00520.33, score=318.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=32.1]; Polycystin cation channel [PF08016.14, score=30.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=660, Expect=0.0]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=654, Expect=0.0]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=649, Expect=0.0]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=640, Expect=0.0]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=639, Expect=0.0]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=635, Expect=0.0]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=631, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=627, Expect=0.0]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=655, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=652, Expect=0.0]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=646, Expect=0.0]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=645, Expect=0.0]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=637, Expect=0.0]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=635, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=630, Expect=0.0]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=623, Expect=0.0]} {Dmel: FBgn0285944, para, paralytic, [Score=701, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=268, Expect=3e-77]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=816, Expect=0.0]} {RNA1310_51142} |
10. | MligTC455_28686 | 23 | 0.47 | Mlig455_011407 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_011407 {REF} {Length: 383} {TRANSSPLICED} {RNA1509_35740} {RNA1310_43519} {RNA815_21134} | |
11. | MligTC455_50119 | 18 | 0.37 | Mlig455_059375 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_059375 {REF} {Length: 132} {NoTransDecoderORF} {RNA1509_25973} {RNA1310_63860} {RNA815_5524} | |
12. | MligTC455_29853 | 45 | 0.94 | Mlig455_026579, Mlig455_044780, Mlig455_054135 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_026579 {REF} {Length: 430} {RNA1310_43414} Mlig455_044780 {REF} {Length: 430} {RNA1310_43414} Mlig455_054135 {REF} {Length: 4050} {Pfam: Transcriptional Coactivator p15 (PC4) [PF02229.18, score=27.4]} {RNA1509_13774} {RNA1310_6053.2} {RNA815_16908} |
|
13. | MligTC455_47805 | 309 | 6.43 | Mlig455_002866, Mlig455_033201 | Neo: - |
NR2C2 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_002866 {REF} {Length: 2397} {RNA1509_25172} {RNA1310_17963.1} {RNA815_11681} Mlig455_033201 {REF} {Length: 2405} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=86.4]} {Human: ENSG00000177463, NR2C2, nuclear receptor subfamily 2 group C member 2, [Score=90.5, Expect=1e-18]; ENSG00000120798, NR2C1, nuclear receptor subfamily 2 group C member 1, [Score=87.8, Expect=4e-18]; ENSG00000101076, HNF4A, hepatocyte nuclear factor 4 alpha, [Score=87.4, Expect=7e-18]; ENSG00000113580, NR3C1, nuclear receptor subfamily 3 group C member 1, [Score=87.4, Expect=2e-17]; ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=87.0, Expect=6e-18]; ENSG00000160113, NR2F6, nuclear receptor subfamily 2 group F member 6, [Score=86.7, Expect=9e-18]; ENSG00000151623, NR3C2, nuclear receptor subfamily 3 group C member 2, [Score=86.7, Expect=3e-17]} {Mouse: ENSMUSG00000005893, Nr2c2, nuclear receptor subfamily 2, group C, member 2, [Score=88.2, Expect=5e-18]; ENSMUSG00000017950, Hnf4a, hepatic nuclear factor 4, alpha, [Score=88.2, Expect=3e-18]; ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=87.0, Expect=5e-18]; ENSMUSG00000031618, Nr3c2, nuclear receptor subfamily 3, group C, member 2, [Score=87.0, Expect=1e-17]; ENSMUSG00000005897, Nr2c1, nuclear receptor subfamily 2, group C, member 1, [Score=86.7, Expect=1e-17]; ENSMUSG00000002393, Nr2f6, nuclear receptor subfamily 2, group F, member 6, [Score=85.9, Expect=9e-18]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=85.1, Expect=2e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=85.1, Expect=4e-17]; ENSMUSG00000024431, Nr3c1, nuclear receptor subfamily 3, group C, member 1, [Score=85.1, Expect=5e-17]; ENSMUSG00000026398, Nr5a2, nuclear receptor subfamily 5, group A, member 2, [Score=84.3, Expect=7e-17]} {Dmel: FBgn0264562, Hr4, Hormone receptor 4, [Score=96.3, Expect=1e-20]} {Celegans: WBGene00003681, nhr-91, Nuclear hormone receptor family member nhr-91, [Score=89.7, Expect=5e-19]} {Smed: dd_Smed_v6_33286_0_2, dd_Smed_v6_33286_0_2, [Score=86.7, Expect=6e-19]} {RNA1509_25172} {RNA1310_17963.1, RNA1509_25172} {RNA1509_25172, RNA815_11681} |
14. | MligTC455_06802 | 19 | 0.4 | Mlig455_033458 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_033458 {REF} {Length: 861} {RNA1310_100612} | |
15. | MligTC455_36850 | 102 | 2.12 | Mlig455_061130 | Neo: - Age: - |
RHBDF2 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_061130 {REF} {Length: 6350} {TRANSSPLICED} {Pfam: Rhomboid family [PF01694.24, score=74.1]} {Human: ENSG00000129667, RHBDF2, rhomboid 5 homolog 2, [RH, Score=362, Expect=7e-112]; ENSG00000007384, RHBDF1, rhomboid 5 homolog 1, [RH, Score=360, Expect=5e-111]} {Mouse: ENSMUSG00000020806, Rhbdf2, rhomboid 5 homolog 2, [RH, Score=366, Expect=1e-113]} {Dmel: FBgn0041723, rho-5, rhomboid-5, [RH, Score=309, Expect=2e-89]} {Celegans: WBGene00004403, rom-4, Rhomboid-like protein, [RH, Score=313, Expect=2e-91]} {Smed: dd_Smed_v6_11534_0_2, dd_Smed_v6_11534_0_2, [RH, Score=410, Expect=3e-132]} {RNA1509_18207} {RNA1310_7108} {RNA815_9193} |
16. | MligTC455_25562 | 10 | 0.21 | Mlig455_042405 | Neo: - Age: - |
KREMEN2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_042405 {REF} {Length: 2000} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=47.2]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=48.1, Expect=5e-06]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1509_39834} {RNA1310_29401} {RNA815_27180} |
17. | MligTC455_30389 | 116 | 2.41 | Mlig455_029602 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_029602 {REF} {Length: 2395} {RNA1509_16871} {RNA1310_10374.1} {RNA815_9291} | |
18. | MligTC455_01648 | 4 | 0.08 | Mlig455_065106 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_065106 {REF} {Length: 495} {NoTransDecoderORF} {RNA1310_110067} {RNA815_57749} | |
19. | MligTC455_21780 | 19 | 0.4 | Mlig455_027652 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_027652 {REF} {Length: 1944} {Pfam: WSC domain [PF01822.21, score=50.5]; PAN domain [PF00024.28, score=19.1]} {RNA1509_53783} {RNA1310_34968.1} {RNA815_24434} | |
20. | MligTC455_11966 | 21 | 0.44 | Mlig455_048087 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_048087 {REF} {Length: 791} {RNA1509_15570} {RNA1310_9037} {RNA815_62132} | |
21. | MligTC455_12062 | 944 | 19.66 | Mlig455_037666, Mlig455_037770 | Neo: - Age: - |
ZFAND5 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_037666 {REF} {Length: 4070} {TRANSSPLICED} {Pfam: AN1-like Zinc finger [PF01428.18, score=38.9]; A20-like zinc finger [PF01754.18, score=25.7]} {Human: ENSG00000107372, ZFAND5, zinc finger AN1-type containing 5, [Score=118, Expect=7e-32]; ENSG00000086666, ZFAND6, zinc finger AN1-type containing 6, [Score=114, Expect=3e-30]} {Mouse: ENSMUSG00000024750, Zfand5, zinc finger, AN1-type domain 5, [Score=114, Expect=1e-30]; ENSMUSG00000030629, Zfand6, zinc finger, AN1-type domain 6, [Score=110, Expect=6e-29]} {Dmel: FBgn0266410, CG45050, [Score=123, Expect=4e-34]} {Celegans: WBGene00009050, F22D6.2, [Score=108, Expect=5e-29]} {Smed: dd_Smed_v6_2038_0_1, dd_Smed_v6_2038_0_1, [Score=112, Expect=2e-30]} {RNA1509_40874} {RNA1310_19403.1} {RNA815_18790} Mlig455_037770 {REF} {Length: 8494} {Pfam: AN1-like Zinc finger [PF01428.18, score=38.9]; A20-like zinc finger [PF01754.18, score=25.7]} {Human: ENSG00000107372, ZFAND5, zinc finger AN1-type containing 5, [Score=118, Expect=7e-32]; ENSG00000086666, ZFAND6, zinc finger AN1-type containing 6, [Score=114, Expect=3e-30]} {Mouse: ENSMUSG00000024750, Zfand5, zinc finger, AN1-type domain 5, [Score=114, Expect=1e-30]; ENSMUSG00000030629, Zfand6, zinc finger, AN1-type domain 6, [Score=110, Expect=6e-29]} {Dmel: FBgn0266410, CG45050, [Score=123, Expect=4e-34]} {Celegans: WBGene00009050, F22D6.2, [Score=108, Expect=5e-29]} {Smed: dd_Smed_v6_2038_0_1, dd_Smed_v6_2038_0_1, [Score=112, Expect=2e-30]} {RNA1509_22778, RNA1509_40874, RNA1509_54344} {RNA1310_19403.1, RNA1509_22778, RNA1509_40874, RNA1509_54344} {RNA1509_22778, RNA1509_40874, RNA1509_54344, RNA815_18790} |